BACK: IMAC Holdings Inc Analyst Consensus Forecast

IMAC Holdings, Inc. (BACK) ensures the seamless supply of consumables for spinal therapy centers, minimizing resource shortages to maintain stable profits. The market price action shown below is recorded at 0.00. Business efficiency relies on the demand for gentle pain management, the availability of specialized professionals, and an insurance reimbursement system that covers patient costs for restorative treatment.

BACK IMAC Holdings, Inc.: Price Target Chart in the range 02/21/2024 - 04/05/2025

Metric breakdowns and analytics for IMAC Regeneration Centers (BACK)

- current price and projected stock value:

Price Chart imacholdings.comm|BACK - Analyst Consensus Forecast

- market capitalization information:

Market Capitalization IMAC Regeneration Centers|BACK - Enterprise Value

- balance sheet equity data:

Accounting Value per Share IMAC Holdings|BACK - Company Book Value|Market Capitalization to Book Value Ratio imacholdings.comm|BACK - Cumulative Company Assets

- debt obligations and liquidity statistics:

- business earnings and investment ratios data:

BACK - Company Net Income|Future Profit IMAC Holdings, Inc.|BACK - P/E Multiple|Projected Price to Earnings Ratio IMAC Holdings Inc|BACK - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation IMAC Regeneration Centers|BACK - Operating profit before deduction of amortization|Earnings per share for the last four quarters IMAC Holdings|BACK - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months imacholdings.comm|BACK - Earnings per share growth in current year|Expected earnings per share growth for next year IMAC Holdings, Inc.

General company analysis:BACK - imacholdings.comm

IMAC Holdings, Inc. (BACK) employs a unique comprehensive approach to joint therapy that ensures high patient loyalty and pricing power, directly impacting the business's fundamental value. The consolidated target forecast from investment houses aggregates expert expectations for the fair value, allowing investors to promptly identify a series of downgrades and assess the issuer's ability to maintain financial discipline over the long term.

Competing companies